Business Segments Masimo Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-17 pm EDT			5-day change	1st Jan Change
159.32 ^USD	-1.98%		-7.31%	-3.62%

Jun. 12	Masimo Corporation Announces Executive Appointments	CI
Jun. 10	Masimo Announces the Findings of A Randomized Clinical Trial Published in Jama Pediatrics	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (USD)

Fiscal Period: December	2020	2021	2022	2023	2024
Medical Testing, Analyzing, and Diagnostic Equipment
Healthcare	-	-	1.34B	1.28B	1.4B
Total Assets	-	-	1.59B	1.63B	1.6B
Gross Profit	-	-	870M	777M	874M
D&A	-	-	36M	38.1M	48.7M
Patient Monitoring and Related Products	1.14B	1.24B	-	-	-
Total Assets	1.71B	1.89B	-	-	-
Interest Expense	-338K	-355K	-	-	-
Income Tax Expense	23.45M	44.73M	-	-	-
CAPEX	-79.96M	-34.93M	-	-	-
EBT	264M	274M	-	-	-
Gross Profit	743M	808M	-	-	-
D&A	29.3M	35.62M	-	-	-
Operating Income	256M	276M	-	-	-
Net Income	240M	230M	-	-	-
Audio Equipment
Non-healthcare	-	-	696M	773M	699M
Total Assets	-	-	1.6B	1.39B	1.01B
Gross Profit	-	-	252M	258M	235M
D&A	-	-	100M	60.1M	54.3M
Total Assets	-	-	19M	19.1M	-
Gross Profit	-	-	-63.9M	-31.6M	-
Total Assets	-	-	-	-	17.4M

Geographical breakdown of sales (USD)

Fiscal Period: December	2020	2021	2022	2023	2024
United States (U.S.)	763M	822M	1.14B	1.06B	1.13B
Total Assets	238M	239M	320M	318M	320M
Europe, Middle East and Africa	239M	252M	524M	572M	596M
Asia and Australia	104M	124M	327M	351M	304M
North and South America (Excluding United States)	38.24M	41.31M	43.7M	66.4M	67.7M
Total Assets	35.76M	36.05M	84.5M	108M	80.6M
Unallocated	-	-	-	-	-